Optimisation of aciclovir poly(D,L-lactide-co-glycolide) microspheres for intravitreal administration using a factorial design study

International Journal of Pharmaceutics

Volumn 273, Issue 1-2, 2004, Pages 45-56

  Martinez Sancho C ^a   Herrero Vanrell, R ^a   Negro, S ^a  

^a UNIVERSIDAD COMPLUTENSE DE MADRID   (Spain)

Author keywords

Aciclovir; Controlled release; Experimental design; Gelatin; Microspheres; PLGA

Indexed keywords

ACICLOVIR; GELATIN; MICROSPHERE; POLYGLACTIN; SOLVENT;

ARTICLE; DRUG FORMULATION; DRUG RELEASE; EMULSION; ENCAPSULATION; EVAPORATION; INJECTION; NEEDLE; PARTICLE SIZE; PRIORITY JOURNAL; SINGLE DRUG DOSE;

ACYCLOVIR; ANTIVIRAL AGENTS; CALORIMETRY, DIFFERENTIAL SCANNING; DRUG COMPOUNDING; EMULSIONS; GELATIN; INJECTIONS; LACTIC ACID; MICROSPHERES; POLYGLYCOLIC ACID; POLYMERS; RESEARCH DESIGN; SOLUBILITY;

EID: 1542328830     PISSN: 03785173     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2003.12.006     Document Type: Article

References (14)

1. Beck L.R., Cowsar D.R., Lewis D.H., Cosgrove R.J., Riddle C.T., Lowry S.L., Epperly T. A new long-acting injectable microcapsule system for the administration of progesterone. Fertil. Steril. 31:1979;545-548.
2. Brigden D., Whiteman P. The clinical pharmacology of aciclovir and its prodrugs. Scan. J. Infect. Dis. Suppl. 47:1985;33-39.
3. Cochran, W.G., Cox, G.M., 1957. Experimental Designs. Wiley, New York.
4. Cohen S., Yoshiaka T., Lucarelli M. Controlled delivery system for proteins based on poly (lactic/glycolic acid) microspheres. Pharm. Res. 8:1991;713-720.
5. Conti B., Bucolo C., Giannavola C., Puglisi G., Giunchedi P., Conte U. Biodegradable microspheres for the intravitreal administration of acyclovir: in vitro/in vivo evaluation. Eur. J. Pharm. Sci. 5:1997;287-293.
6. Gotti R., Furlanetto S., Andrisano V., Cavrini V., Pinzauti S. Design of experiments for capillary electrophoretic enantioresolution of salbutamol using dermatan sulphate. J. Chromatogr. A. 875:2000;411-422.
7. Herrero-Vanrell R., Refojo M.F. Biodegradable microspheres for vitreoretinal drug delivery. Adv. Drug Deliv. Rev. 52:2001;5-16.
8. Hughes P.M., Krishnamoorthy R., Mitra A.K. Vitreous disposition of two acycloguanosine antivirals in the albino and pigmented rabbit models: a novel ocular microdialysis technique. J. Ocul. Pharmacol. Ther. 12:1996;209-224.
9. Lemaire V., Bélair J., Hildgen P. Structural modeling of drug release from biodegradable porous matrices based on a combined diffusion/ erosion process. Int. J. Pharm. 258:2003;95-107.
10. Martínez-Sancho C., Herrero-Vanrell R., Negro S. Poly (D,L-lactide-co-glycolide) microspheres for long-term intravitreal delivery of aciclovir: influence of fatty and non-fatty additives. J. Microencapsul. 20:2003;799-810.
11. McCarron P.A., Woolfson A.D., Keating S.M. Response surface methodology as a predictive tool for determining the effects of preparation conditions on the physicochemical properties of poly(isobutylcyanoacrylate) nanoparticles. Int. J. Pharm. 193:1999;37-47.
12. Tzafriri A.R. Mathematical modelling of diffusion-mediated release from bulk degrading matrices. J. Control. Release. 63:2000;69-79.
13. Vandervoort J., Ludwig A. Biocompatible stabilizers in the preparation of PLGA nanoparticles: a factorial design study. Int. J. Pharm. 238:2002;77-92.
14. Visscher G.E., Robison R.L., Maulding H.V., Fong J.W., Pearson J.E., Argentieri G.J. Biodegradation of and tissue reaction to 50:50 poly(D,L-lactide-co-glycolide) microcapsules. J. Biomed. Mater. Res. 19:1985;349-365.